Sunday, April 19, 2026

UnitedHealthcare announced it will eliminate prior authorizations for most services provided to its Medicare Advantage and commercial plan members by rural providers. The change, part of a 'rural health financial stability program,' takes effect immediately for participating providers. UHC cited reducing administrative burden for small clinics as the goal. Rural practices with UHC contracts should confirm their eligibility and review the updated authorization list through the UHC provider portal to adjust their front-office workflows.

CMS published a proposed rule to establish national interoperability and prior authorization standards for drugs covered by Medicare Advantage, Medicaid, CHIP, and Qualified Health Plans. The rule mandates payers build APIs to provide real-time patient coverage and benefit data, respond to prior authorization requests for drugs within 72 hours for standard requests and 24 hours for urgent cases, and publicly report metrics on approval and denial rates. The 60-day comment period closes in mid-June 2026. Monitor the CMS docket (CMS-2026-XXXX) for the final rule, which would force payer portals to modernize and could reduce follow-up calls on drug coverage.

The CMS WisER program, a federal AI-driven prior-authorization initiative in Washington state, is creating care delays for seniors according to a report cited by Senator Patty Murray. The program's reliance on algorithmic decision-making is increasing administrative burden for providers and extending wait times for approvals. CMS is reviewing the program's impact. Monitor the WisER demonstration project for operational updates, as findings could shape future national Medicare Advantage prior-authorization rules.

Representatives Pramila Jayapal and Ro Khanna introduced legislation to eliminate prior-authorization requirements for all services in Medicare Advantage plans. The bill, driven by complaints of care denials and administrative overhead, would mandate coverage determinations at the point of care. While the bill faces a long legislative path, it signals mounting political pressure on payer utilization management practices. Track H.R. [bill number] as it moves through committee; its introduction alone may push MA plans to preemptively streamline certain approval processes.

CMS and the FDA jointly announced the RAPID Coverage Pathway, a new voluntary program designed to accelerate Medicare coverage for FDA-designated breakthrough devices. The program aims to align FDA approval and CMS coverage decisions, potentially reducing the typical multi-year lag for new technology reimbursement. For practices that adopt new devices, this could mean fewer coverage gaps and denials for patients. The pathway is now accepting applications; device manufacturers will drive participation. No immediate action is required from providers, but this signals a shift toward faster reimbursement cycles for innovative care.